Latest News and Press Releases

Pune, May 04, 2023 (GLOBE NEWSWIRE) -- Maximize Market Research, an international business & consultancy firm has recently published a research report on the “Marine Scrubber Market”. The total...

NEW YORK, United States, May 04, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Cell-Based Assays Market By Product & Service (Reagents, Cell Lines,...

Q1 2023 total revenues of $95.3 million, compared to $35.0 million in the same period in 2022 CAPLYTA Q1 2023 net product sales were $94.7 million, compared to $34.8 million for the same period in...

- Record sales, and adjusted segment operating margin, EBITDA margin, net income and EPS- Sales increased 24% to $5.1 billion; organic sales increased 12%- Segment operating margin was 18.8%, or 23.2%...

New York, May 04, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Translucent Concrete Industry" - https://www.reportlinker.com/p06033161/?utm_source=GNW Food...

NEW YORK, May 04, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the...

GAITHERSBURG, Md., May 04, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2023 financial...

Additional AB-729 off-treatment data highlighted in an oral presentation at the Global Hepatitis Summit 2023 Dosed first subject in Phase 1 clinical trial with oral RNA Destabilizer, AB-161 Filed...

Consolidated sales increased 3% from prior year periodContinued strength across each business segment ATCHISON, Kan., May 04, 2023 (GLOBE NEWSWIRE) -- MGP Ingredients, Inc. (Nasdaq:MGPI), a leading...

First-of-its-Kind Study in HIV Compares Ibalizumab Clinical Trial Experience to Matched Real-World Non-Ibalizumab OPERA® CohortData Presented at ACTHIV™ Conference Highlight Improved Clinical Outcomes...